Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression

Current Eye Research

Volumn 30, Issue 5, 2005, Pages 395-403

  Zhang, Xinyuan ^a,b   Barile, Gaetano ^a,c   Chang, Stanley ^a   Hays, Arthur ^a   Pachydaki, Sophia ^a   Schiff, William ^a   Sparrow, Janet ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Box 94 ^*  (United States)

Author keywords

Apoptosis; Cell proliferation; Macular pucker; Proliferative diabetic retinopathy; Proliferative vitreoretinopathy

Indexed keywords

ANTIBODY; CASPASE 3; CYCLINE; CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P85;

ADULT; AGED; ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DRUG TARGETING; EPIRETINAL MEMBRANE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; NICK END LABELING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; RETINA DETACHMENT; RETINOPATHY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CASPASE 3; CASPASES; CELL PROLIFERATION; CHILD; EPIRETINAL MEMBRANE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MIDDLE AGED; POLY(ADP-RIBOSE) POLYMERASES; PROLIFERATING CELL NUCLEAR ANTIGEN; RETINAL DETACHMENT; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 21344468163     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590956306     Document Type: Article

References (31)

1. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study. Br J Ophtalmol. 1984;68:708-715.
2. Clarkson JG, Green WR, Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1997;84(1):1-17.
3. Machemer R, van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85:181-191.
4. Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol. 1990;74:393-399.
5. Barile GR, Chang S, Park LS, Reppucci VS, Schiff WM, Schmidt AM. Soluble cellular adhesive molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res. 1999;19:219-227.
6. Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC Jr. Reoperation following diabetic vitrectomy. Arch Ophthalmol. 1992;110:506-510.
7. Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 1998;21:1759-1763.
8. Pray TR, Parlati F, Huang J, Wong BR, Payan DG, Bennett MK, Issakani SD, Molineaux S, Demo SD. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat. 2002;5:249-258.
9. Nickoloff BJ, Qin JZ, Chaturvedi V, Bacon P, Panella J, Denning MF. Life and death signaling pathways contributing to skin cancer. J Investig Dermatol Symp Proc. 2002;7:27-35.
10. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology. 1998;122:552-562.
11. Kanitakis J, Narvaez D, Euvrard S, Faure M, Claudy A. Proliferation markers Ki-67 and PCNA in cutaneous squamous cell carcinomas: Lackof prognostic value. Br J Dermatol. 1997;136(4):643-644.
12. Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol. 1996;48:175-181.
13. Yu CC, Woods AL, Levison DA. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem J. 1992;24:121-131.
14. Duchrow M, Gerdes J, Schluter C. The proliferation-associated Ki-67 protein: Definition in molecular terms. Cell Prolif. 1994;27:235-242.
15. Naiem M, Gerdes J, Abdulaziz Z, Stein H, Mason DY. Production of a mouse monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol. 1983;36(2):167-175.
16. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987;326:515-517.
17. Kelman Z. PCNA: Structure, functions and interactions. Oncogene. 1997;14:629-640.
18. Bethwaite PB, Delahunt B, Holloway LJ, Thornton A. Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma. Pathology 1995;27:1-4.
19. Heidenkummer HP, Kampik A, Petrovski B. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Retina 1992;12:52-58.
20. Martinou JC, Desagher S, Antonsson B. Cytochrome c release from mitochondria: All or nothing. Nat Cell Biol. 2000;2:E41-E43.
21. Li H, Yuan, J. Deciphering the pathways of life and death. Curr Opin Cell Biol. 1999;11:261-266.
22. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513-519.
23. Esser P, Heimann K, Bartz-Schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M. Apoptosis in proliferative vitroretinal disorders: Possible involvement of TGF-beta induced RPE cell apoptosis. Exp Eye Res. 1997;65:365-378.
24. Weller M, Heimann K, Bartz-Schmidt KU, Fontana A, Esser P. CD 95 expression in traumatic proliferative vitreoretinopathy: A target for the induction of apoptosis. Ger J Ophthalmol. 1996;5:332-337.
25. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
26. Ito Y, Otsuki Y. Localization of apoptotic cells in the human epidermis by an in situ DNA nick end-labeling method using confocal reflectant laser microscopy. J Histochem Cytochem. 1998;46:783-786.
27. Hinton DR, He S, Lopez PF. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol. 1998;116:203-209.
28. Gould VE, Koukoulis GK, Jansson DS, Nagle RB, Franke WW, Moll R. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am J Pathol. 1990;137:1143-1155.
29. Guo Y, Sigman DB, Borkowski A, Kyprianou N. Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients. Prostate 2000;42:130-136.
30. El Ghrably I, Powe DG, Orr G, Fischer D, McIntosh R, Dua HS, Tighe PJ. Apoptosis in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2004;45(5):1473-1479.
31. Mandava N, Blackburn P, Paul DB, Wilson MW, Read SB, Alspaugh E, Tritz R, Barber JR, Robbins JM, Kruse CA. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2002;43:3338-3348.